Alternatives to Quince Therapeutics
Quince Therapeutics is a Biotechnology tool: A biopharmaceutical company focused on developing novel therapies. Here are the 55 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotechnology companies to Quince Therapeutics
Rocket PharmaceuticalsNot ratedA biotechnology company developing genetic therapies for rare disorders.
Immix Biopharma, Inc.Not ratedA clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.
Anagram TherapeuticsNot ratedClinical-stage biopharmaceutical company developing novel treatments for exocrine pancreatic insufficiency.
Verdiva Bio3.0 out of 5 (1)Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.
TG TherapeuticsNot ratedA commercial-stage immunotherapy company focused on the development of novel treatments for B-cell malignancies and autoimmune diseases.
Adaptimmune TherapeuticsNot ratedBiopharmaceutical company developing T-cell therapies for solid tumor cancers.
ONCOMATRYXNot ratedDeveloping Quantum ADCs against the tumor microenvironment for innovative cancer therapies.
DiaMedica TherapeuticsNot ratedClinical-stage biopharmaceutical company developing novel treatments for serious ischemic and vascular diseases.
- GEGenexineNot rated
South Korean biopharmaceutical company developing novel biologics for cancer and rare diseases.
AdociaNot ratedA clinical-stage biopharmaceutical company focused on innovative therapeutic solutions for diabetes and obesity.
argenxNot ratedGlobal immunology company developing antibody-based therapies for severe autoimmune diseases.
Moderna2.5 out of 5 (2)Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Kite PharmaNot ratedBiotechnology company developing and commercializing cell therapies for cancer treatment.
- JUJuno TherapeuticsNot rated
Biotechnology company focused on developing cancer immunotherapies.
CRISPR TherapeuticsNot ratedBiotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.
Degron TherapeuticsNot ratedClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
Seaport TherapeuticsNot ratedDeveloping novel therapeutics to restore gut lymphatic function.
Supernus PharmaceuticalsNot ratedBiopharmaceutical company developing and commercializing CNS disease treatments.
CellCentricNot ratedA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
InfinimmuneNot ratedDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
Showing the next 20 closest matches. See the rest on the Quince Therapeutics profile.
Sponsored rows are paid and labelled. Advertise on this page
